BioSpace News Archive

Innate Pharma SA announced its revenue and cash position for the three-month period ended March 31, 2020.

Protagonist Therapeutics, Inc., a clinical stage biopharmaceutical company, announced the pricing of its previously announced underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $14.00 per share.

As home care captures the imagination of people, mainly for convenience and cost associated reasons, particularly in regions where reimbursement policies are weak, contribute heavily to the demand for global pulse oximeter market.

Cell-to-cell variety and heterogeneity are central and natural qualities of undifferentiated bacteria population, however these distinctions are covered when mass cells are utilized for omics diagnosis.

In terms of revenue, the multiple sclerosis drugs market is projected to expand at a CAGR of ~6% during the forecast period, due to numerous factors, about which TMR offers comprehensive insights and forecasts in the global multiple sclerosis drugs market report.

Transparency Market Research has published a new report titled, ‘Medical Tourism Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today reported its financial results for the quarter ended March 31, 2020 and provided a business update.

Forward Pharma A/S, announced that due to current precautionary measures against the spread of the novel coronavirus, the Technical Board of Appeal of the European Patent Office has rescheduled the oral hearing of the appeal against the decision of the Opposition Division that revoked the EP2801355 patent.

Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, is scheduled to participate in a virtual presentation and fireside chat at the May 2020 Lytham Partners Virtual Investor Conference on Wednesday, May 20, 2020 at 12:00pm ET (9:00am PT).

CRH Medical Corporation announced financial and operating results for the three months ended March 31, 2020.